IL27RA and graft versus host disease: Drobyski et al. previously reported that inhibiting the IL-27 signaling pathway via anti-IL-27p28 Ab treatment or genetic deletion of the IL-27R results in reduced GvHD development, and the reduction is mostly attributed to enhanced Treg reconstitution/generation (25).